Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, ...

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.

Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. (HealthDay News) — A single combined measure of high-sensitivity C-reactive protein (CRP), ...

Higher lipoprotein(a) (Lp[a]) levels are associated with greater baseline coronary artery plaque burden and faster long-term plaque progression. Studies of Lp(a)-lowering therapies are underway.

Pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) are produced in large quantities locally in the joints and subsequently enter the bloodstream. TNF-α and IL-6 may promote LDL metabolism by ...

INDIANAPOLIS (WISH) — An Indianapolis doctor is raising awareness for what she calls a “hidden heart risk.” The American Heart Association recognizes February as American Heart Month. Dr. Kristi ...

Your doctor hands you a cholesterol report filled with abbreviations and numbers. The test measures four key components that predict the risk of heart disease and stroke. Understanding what these ...